The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Home
Audio Interview: FDA Progress Report and QbD Update
Emil Ciurczak speaks with Moheb Nasr, director of FDA's Office of Drug Quality, on developments at the Agency and Quality by Design (QbD).
Feb. 7, 2008
Click below to listen.
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Fujifilm Biotechnologies to leverage downstream purification system at UK site
‘Cobots’ drive pharma’s shift toward scalable cell therapies
Sponsored
Webinar: 2026 Life Sciences Industry Trends: Connecting Quality, Manufacturing, and Asset Management
Sponsored
Accelerating Pharma Digital Transformation: Live Webinar with ISPE
Trending
Sun Pharma invests in new manufacturing facility in India amid FDA scrutiny
States competing for biomanufacturing investment turn to financial incentives
US pharma manufacturing investments reaching unprecedented levels: report
Sponsored Picks
Sponsored
Webinar: 2026 Life Sciences Industry Trends: Connecting Quality, Manufacturing, and Asset Management
Sponsored
Accelerating Pharma Digital Transformation: Live Webinar with ISPE
Sponsored
AI Compliance in Life Sciences: 5 Essentials
Load More Content